Management of Fever During IVIG Infusion
If fever develops during IVIG infusion, immediately stop the infusion and assess for signs of severe hypersensitivity or anaphylaxis before determining whether to resume at a slower rate.
Immediate Assessment and Action
When fever occurs during IVIG infusion, you must first distinguish between a mild infusion reaction versus a potentially life-threatening hypersensitivity reaction:
Stop the infusion immediately and perform a rapid assessment 1:
- Check vital signs: Blood pressure, heart rate, respiratory rate, oxygen saturation, temperature
- Assess for anaphylaxis signs: Hypotension (SBP drop ≥30 mmHg or SBP ≤90 mmHg), angioedema, stridor, bronchospasm, generalized urticaria, loss of consciousness
- Evaluate concurrent symptoms: Chills, rigors, headache, myalgia, back pain, nausea, chest tightness
Classification and Management Algorithm
Mild Reaction (Fever with minimal other symptoms)
If fever occurs with only mild symptoms (chills, mild headache, myalgia) and no signs of anaphylaxis:
- Maintain IV line with normal saline at keep-vein-open rate 2
- Administer symptomatic treatment:
- Acetaminophen 650-1000 mg (or per institutional protocol)
- Consider diphenhydramine 25-50 mg IV if concurrent pruritus
- Monitor for ≥15 minutes until symptoms resolve 2
- Consider rechallenge: After symptom resolution, restart infusion at 50% of the initial rate 2
- If well tolerated for 15 minutes, may gradually increase rate
Moderate Reaction (Fever plus concerning features)
If fever occurs with transient cough, shortness of breath, tachycardia, or mild hypotension:
- Keep infusion stopped
- Administer:
- If hypotensive: Recline patient and administer NS bolus 1000-2000 mL 2
- Monitor closely until return to baseline
- Do not rechallenge until patient is completely stable and physician evaluation completed
Severe Reaction/Anaphylaxis
If fever occurs with hypotension (SBP drop ≥30 mmHg), angioedema, respiratory distress, or multi-organ involvement:
- Call emergency response team immediately
- Administer epinephrine 0.3 mg IM (anterolateral thigh) - may repeat once 2, 1
- Give oxygen by mask or nasal cannula
- Administer:
- Epinephrine (as above)
- IV steroids (hydrocortisone 100-500 mg)
- Antihistamines
- Albuterol 0.083% nebulizer if bronchospasm 2
- Permanently discontinue IVIG 1
- Cardiorespiratory support as needed
Important Clinical Context
Fever during IVIG is a recognized moderate adverse reaction that typically begins at the end of infusion and can continue for hours 3. The guidelines specifically note that chills, fever, headache, myalgia, and fatigue are expected moderate reactions that may require pretreatment with corticosteroids or acetaminophen if another dose is needed 3.
However, fever can also be the presenting sign of more serious complications including:
- Anaphylaxis (which can progress to death) 3, 1
- Aseptic meningitis syndrome (characterized by severe headache, nuchal rigidity, drowsiness, fever, photophobia) 3
Risk Factors and Prevention
Patients at higher risk for infusion reactions 2, 4, 5:
- History of severe asthma or eczema
- Multiple drug allergies
- Prior reaction to IVIG
- IgA deficiency with anti-IgA antibodies (contraindication) 1
- Concurrent infection (elevated CRP associated with increased reaction risk) 6
Preventive strategies 2, 1, 4, 5:
- Start infusion at slow rate: For IVIG, initial rate of 1-2 mg/kg/min, gradually increasing to maximum 8 mg/kg/min if tolerated 1
- Ensure adequate hydration before infusion
- Consider premedication in high-risk patients: acetaminophen, antihistamines
- Delay infusion if active infection present 6
Common Pitfalls to Avoid
- Do not resume infusion at the same rate after a reaction - always restart at 50% of initial rate 2
- Do not dismiss fever as "just an infusion reaction" without ruling out anaphylaxis or aseptic meningitis
- Do not continue infusion in patients with concurrent infection and elevated inflammatory markers 6
- Do not use IVIG in IgA-deficient patients with anti-IgA antibodies - this is an absolute contraindication 1
- Have epinephrine immediately available at bedside before starting any IVIG infusion 1
The key principle is that while fever during IVIG is common and often manageable, it requires immediate cessation of infusion and careful assessment to exclude life-threatening complications before any consideration of resuming therapy.